The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
MSD – Shifting Paradigms For Critically Ill Patients With Gram-Negative Infections: Redefining Treatment Strategies
Room:
111
Facilitator:
Abstract:
Shifting Paradigms for Critically Ill Patients with Gram-negative Infections:
Redefining Treatment Strategies
This satellite symposium addresses the challenges posed by antibiotic therapy in the critically ill, particularly regarding the treatment of gram negative infections. It takes a patient-centric approach to the individualization of treatment approaches by considering local ecology, risk factors, clinical symptoms, co-morbidities, guidelines, real world evidence and antimicrobial stewardship principals. Additionally, it will cover how the microbiology lab can be used to enhance antimicrobial stewardship,and discuss emerging therapies for high risk patients.